Impact of Organizational Culture on Success

This assignment delves into the critical role of organizational culture in shaping business success. It examines various dimensions of organizational culture, including its impact on employee satisfaction, motivation, communication, and overall decision-making processes. The analysis draws upon a range of academic sources to illustrate how a positive and supportive organizational culture can contribute to enhanced productivity, innovation, and customer loyalty.

Organizational Analysis1
Analysis of the joint venture between Pfizer Inc. and Zhejiang Hisun pharmaceuticals
Name
Institution

Organizational Analysis2
Question One: First off we start by analyzing the deal using Michael E. Porter’s model, the
reasons for the joint venture and the involvement of the U.S. and Chinese governments in the
deal.
1. Competitive Rivalry
In this segment we look at the competition in the Active Pharmaceutical Ingredients (API)
manufacturing industry. Notably, in china there is a shortage of top quality API manufacturing
companies. India is a larger base for most leading API manufacturers in the Asian continent. It
was therefore prudent for Pfizer and Hisun to close this joint venture to take advantage of this
gap in the industry and establish itself as the first leading API manufacturer in China. Moreover
Chinese laws and tax code system favor API manufactured in China.
2. Supplier power
China is a low cost country. The cost of labor and other factors of production are comparatively
lower than in the United States of America. As a consequence, setting up operations in Zhejiang
province of China would confer Pfizer-Hisun competitive advantage as opposed to Pfizer on its
own operating in the US. In Zhejiang China the supply of labor and other factors of production
are abundant and the likelihood of suppliers manipulating prices to the disadvantage of the joint
venture is unlikely. This seems exactly what Hisun-Pfizer needs to do to stay at the top by
producing better products. Taking time to grow your suppliers is also very important (Hales et al.
2015). They further say it’s advantageous to build your best suppliers.
3. Buyer power
Michael E Porter postulates that where a business is dealing with a few savvy customers then
they have power over the business and can dictate terms. They may also easily switch to other
rival alternatives for the same goods or services. But where the business is dealing with a large
number of customers, its power over customers is increased. China’s ever growing population
which stands at not less than 1.3 billion offers the kind of large market base that Pfizer-
Hisunwould need in order to have the upper hand when dealing with customers. This must have
been a fundamental reason for the pursuit of this joint venture. The power of customers plays a

Organizational Analysis3
critical role in business and many companies have taken their time to ensure that they provide
and create a good customer base while maintaining performance (Schwepker, 2017). This is to
create a good customer base which is something that Hisun-Pfizer desperately needs.
4. Threat of new entry
Although the pharmaceutical manufacturing is a tightly regulated industry in China, Zhejiang
and Pfizer alike had to stay alive to the possibility of a new entrant coming in and posing
competition to them. As such it was vital that they pursue the joint venture in order to expand
their hold on the market and make it near impossible for another entrant to target the same
market. In the business world, it is all about knowing who the right person is to partner with or
what can be called strategic alliance (Hawlena, 2012) which is exactly what the Hisun-Pfizer
merger deal brings to the table. Hisun-Pfizer is projected to have an aggregate investment of
$295 million. When it comes to registered capital, it stands at $250 million. This financial
strength effectively locks down this market segment from competition from new entrants
In the face of globalization, (Abidin, 2014) posits that competition is ever-increasing and
choosing the best strategy to beat competition is very vital.The power of suppliers is another
factor that in turn increases the competition in the sense that others can threaten to reduce their
prices to get more customers. In this it’s all about taking time and making sure you use your
special qualities to improve your products (Terrero, 2017). Taking time to grow your suppliers is
also very important (Hales et al. 2015). They further say it’s advantageous to build your best
suppliers.
According to MorningStar Ratings, the financial fortunes of Pfizer Inc. in the period leading up
to the signing of the joint venture were not the promising. The net profits of the company
stagnated at an average USD 8 million between 2007 and 2010. This shows that the company
was hurting from the effects of the economic recession that began in the onset of 2008. As a
consequence the firm had to look into ways of finding new markets and stronger partners in
order to cushion it from such adverse consequences in the future. Indeed after the completion of
the signing of the framework for the joint venture with Hisun, the company’s net income rose to
over USD 14570 million. During the same period the Chinese economy was relatively stable:
according to the IMF, while most of the world’s leading economies were struggling in the wake

Organizational Analysis4
of the financial crisis of 2007-09, China accounted for more than half the increase in world GDP
andremained almost unshaken, standing out as the engine of growth in the global
economybecause of the governments bailout expenditure on Chinese firms and the public sector.
This made China a desirable market to venture in for Pfizer.
The involvement of the two governments in the negotiations leading up to the sealing of the deal
is yet another factor that facilitated the formation of this joint venture. The Chinese government
must have been in support of the joint venture and subsequent setting up of operations in Fuyang,
Zhejiang province of china as this would locate production of the generic medicines closer to the
Chinese consumers as well as create job opportunities for the people of China.
The first signing of the Memorandum of Understanding to initiate the joint venture between
Hisun and Pfizer took place during the visit by a delegation from the Zhejiang Provincial
Government to the U.S. in June 2011. This would be followed by the visit by Chinese Vice
President, Mr. Xi Jinpingto the U.S. in February 2011 which saw the two companies sign the
Framework Agreement. This was done at the Sino-US Economic & Trade Cooperation Forum
held in Los Angeles at a ceremony graced by Mr. Xi and U.S. Secretary of Commerce, John
Bryson, as well as several other senior officials from China and the U.S. This high level
involvement of senior government officials from both countries set the establishment of the joint
venture in motion. The U.S. government was driven by market seeking motives and was
interested in seeking new market for Pfizer, one of its leading pharmaceutical companies through
this deal while China sought an efficient way to produce some of the best generic medicines
closer to its people. The U.S. stands to rake in millions in profit from making foreign direct
investments in China and Asia by extension through opportunities that are availed by this joint
venture.
Question 2: The business partnership with its associated risks compared to Pfizer Inc.’s
partnership with Hospira Inc.
The deal signed between Pfizer Pharmaceuticals and Hisun Zhejiang is a joint venture.
Theobjectiveof this joint venture is to enable Hisun-Pfizer to take advantage of the product
portfolio enjoyed by Hisun, better utilize the broad market outreach as well as the expertise of
Pfizer in research and development and commercialization of branded generic drugs. The joint

Organizational Analysis5
venture also seeks to gain from Pfizer’s R&D, quality of manufacturing and manufacturing
quality management and reap from international market promotion at Pfizer not forgetting its
operational capabilities. But therein laysthe risks associated to organizational fit and cultural fit.
Marrying the two organizations cultural practices could pose teething problems to the joint
venture as is usually witnessed with the take -off of suchventures.in order that employees from
the U.S. and China from either organization to begin working as one, reconciliation of
organizational cultures to ensure cultural fit is necessary. According to (Shu et al. 2017), joint
ventures like Pfizer-Hisun are constantly faced with the risk of “coopetition” (competition
between the factions of the joint venture) which is not good for business.
When it comes to share price the companies are almost at par with Hisun at 51% kicking in $295
million, and 75 products as well as knowledge of local market while Pfizer invested $250 million
representing 49% and 8 products. Apart from this Pfizer also brought in all of the know-how of a
world-leading drug maker to Hisun Pfizer Pharmaceutical.This gives the parties to the joint
venture a fair and equal power at decision making in the business which could be a source of
stability. The risk of splitting up is that either the companies can continue to act as separate
players or otherwise cease to operate in a certain region (Siddiqui&Farooq, 2017). As much as a
joint venture sounds like a deal that will bring a lot of profits, there is also the probability of
negative consequences in play (Arnold, 2015). There is also the issue of culture in play which
offers a very good platform for partnerships and businesses to grow. There has been a growing
concern on whether the Chinese culture promotes or deters businesses (He & Jackson, 2015).
The challenge posed by this is that it takes time for individuals from different organizational
cultures to be able to work in harmony at Hisun-Pfizer.
The joint venture is however different from the deal between the Pfizer Inc. and Hospira in that
Pfizer Inc. planned to buy Hospira. The acquisition according to (The Chemical Engineer,
2015)seemed to be a viable deal because it would have eliminated competition by buying off
Hospira, one of its major Pfizer’s major competitors in the generic medicines manufacturing
sector. This would have givenPfizer a wider market which in turn results to more profits. But the
deal was set to cost somewhere between USD 15-17 billion which compared to the joint venture
with Zhejiang (where Pfizer put in only USD 250 million) was much more expensive. Although
the acquisition of Hospira Inc. would have eliminated the managerial complications that can be

Organizational Analysis6
brought about by joint ventures, the deal was far too expensive and could have been untenable
for Pfizer. At the same time acquisition of a U.S owned firm like Hospira Inc. does not come
with the benefits of making foreign direct investments in a low cost country like China which
translates to high profit margins
Question 3: Impact of Organizational Culture in the partnership
This section is dedicated to analyzing how the national and organizational cultures of the two
different countries: U.S. and China could potentially impact on the joint venture. This is with
reference to Hosftede’s model of Cultural dimensions. Organizational culture refers to the
system of belief and norms created within members of an organization which they hold dear
(Lupsa-Tataru, 2016). This means it affects the organization how it works within and without.
Hofstede’s Cultural Dimension
1. Power distance index (PDI)
This refers to the inequalities that exist in the distribution of power and responsibilities and are
accepted by the people of a country. In a high PDI country like China, where people generally
have accepted the disparities between those with power and without, employees are less likely to
initiate tasks and are in fact likely to wait to be guided in order to complete tasks. This could be a
source of conflict for smooth operations at Hisun-Pfizer since U.S. is a high DPI country.
2. Individualism Versus Collectivism
This makes references to the ties that people have to others in the community. A country like
China which is communist is a collectivist society where individuals are likely to take
responsibilities for others in the team. However the U.S citizens could find this strange while
working with the Chinese since the U.S. is a high IDV country where individualism is exalted.
There is also the issue that the organization may seem to be unified with its organizational
culture yet the people who make up the organization are incoherent (Ellinas et al. 2017). This
presents a challenge as some of the employees may not accept or conform to the company’s
culture making it hard to perform to their best.
3. Masculinity Versus Femininity (MAS)

Organizational Analysis7
This makes reference to the distribution of roles between males and females in the society. In
patriarchal society like China, the roles of men and women rarely overlap. On the contrary, the
U.S employees at Hisun-Pfizer are accustomed to a system where men and women tend to take
on almost similar responsibilities. Hisun-Pfizer will have to find a balance between these two so
that their employees work smoothly.
4. Pragmatic versus Normative (PRA)
In this regard, Hofstede’s Model highlights the extent to which individuals need to understand
the inexplicable. It is inherently tied to nationalism and religion. The U.S tends to have a
normative approach where short term goals are exalted, no wonder they prepare statements of
accounts quarterly for instance. Chinese nationals are more pragmatic and tend to be thriftier and
long term oriented. These are aspects that would need to be understood by the leadership and
management of Hisun-Pfizer in order to ensure smooth operations (Pilav&Jatic, 2017). Hisun-
Pfizer needs to look at this considering the fact that these companies belong to countries which
are competing for world dominance which may lead to culture superiority issues. For businesses
to improve in performance, they have to ensure that they take time and invest on developing
better organizational culture (Latif&Ullah, 2016)
The Hisun-Pfizer deal and exchange rates
This paper proposes hedging as in (Dohring, 2008) as an avenue that Hisun-Pfizer can employ
domestic-currency invoicing and hedging in order to reduce itsvulnerability to variations in
exchange rate firstly with regard to transaction risk i.e. the risk of changes in of the value of
committed future cash flows). The same is still suitable for cushioning the joint venture against
the variations inthe value of assets and liabilities denominated in foreigncurrency. This poses a
risk called translationrisk. In order to take care of the broader economic risk, which entails the
impact of variations and competitiveness of exchange rate variations, Hisun-Pfizer can pursue
hedging (neutralization)using the following foreign exchange derivatives.
Forward Contract

Organizational Analysis8
Quite similar to futures contract, a forward contract is a slightly different agreement that allows
the business to buy or sell whatever amount of a currency at a price which is pre-established on a
particular date set in the future (Madura, 2008).As opposed to a futures contract, however, profits
and losses that accrue on a forward contract are only payable upon expiry of the contract.
Forward contracts are bought and on an over-the-counter basis between the buyer and seller. But
unlike futures contracts, forwards are not regularly traded on exchanges. This allows the
company like Hisun-Pfizer to trade on exchange without the risk of running into losses.
Option Contract
With a currency option, the investor has the right, but is not the obligated, to buy or sell a
quantity of currency at a pre-established price by the date of expiry of the option. “Call option”
refers to the right of the investor to sell the currency while and the right to buy is referred to as a
“put option.” The Options approach allows investors to take advantage of more favorable prices
in the event that market conditions vary after the purchase of the option is made.
Buying a call option, can be used for instance as insurance against the risk of a rising exchange
rate, while at the same time the investor can use the “put option” to cushion against the risks
associated with a falling exchange rate. Both of these can be used by Hisun-Pfizer in order to
insulate the joint venture from adverse effects in the face of dwindling exchange rates.
According to a study conducted in the new Asian markets when stock market volatility increases
then the exchange rates improve (Lee et al. 2011). Another study conducted in France reveals
some very interesting facts: the real exchange rate decreased which was not in line with the
traded stocks (Mitra, 2017). This makes you ask whether an appreciation of stock market will
accrue for Hisun-Pfizer thanks to the joint venture and will lead to a decrease in the exchange
rates. Maybe this is unlikely since the author acknowledges that this is particularly rampant in
France.

Organizational Analysis9
References
Abidin, N.Z., Adros, N, A., & Hassan, H. (2014).Competitive Strategy and Performance of
Quantity Surveying Firms in Malaysia. Journal of Construction in Developing
Countries, 19(2), 15-32
Arnold, B (2015). Joint Venture/Joint Venture Exposure.Internal Auditor, 72(2), 57
Barennes, H., Empis, G., Quang, T. D., Sengkhamyong, K., Phasavath, P., Harimanana, A., &…
Koffi, P. N. (2012). Breast-Milk Substitutes: A New Old-Threat for Breastfeeding Policy
in Developing Countries. A Case Study in a Traditionally High Breastfeeding
Country.Plos ONE, 7(2), 1-9.doi:10:1371/journal.pone.0030634
Belias, D., Velissariou, E., Kyriakou, D., Gkolia, A., Sdrolias, L., Koustelios, A, &Varsanis, K.
(2016).The Advantage of Organizational Culture in Greek Banks.Journal of
Management Research (09725814), 16(3), 123
Canco, I. (2016). Evaluation on the impact of organizational culture in decision-making
methods.Proceedings of the Multidisciplinary Academic Conference, 133-145
Cernas Ortiz, D. A, & Miles, G, E. (2014). THE EFFECT OF INTER-PARTNER
RELATEDNESS ON STOCK MARKET REACTIONS TO JOINT VENTURE
ANNOUNCEMENTS: DIFFERENCES BETWEEN MANUFACTURING AND
MARKETING DEALS. Journal of Business Strategies, 31(2), 312
Döhring, B., &Temprano-Arroyo, H. 2008. Implications of EMU for global macroeconomic and
financial stability. Brussels: Office for Infrastructures and Logistics.
Ellinas, C., Allan, N., & Johansson, A. (2017). Dynamics of organizational culture: Individual
belief vs. social conformity. Plos ONE, 12(6), 1-20.doi:10:1371/journal.pone.0180193
Frank, R. G., Hartman, R. S. (2015). The nature of Pharmaceutical Competition: Implications for
Antitrust Analysis. International Journal of the Economics of Business, 22(2),
301.doi:10.1080/13571516.2015.1045745

Organizational Analysis10
Hafeez-ur-Rehman, Jaffri, A. A., & Ahmed, I, (2010).Impact of Foreign Direct Investment (FDI)
Inflows on Equilibrium Real Exchange Rate of Pakistan.South Asian Studies (1026-
678X), 25(1), 125-141
Hales, M., Goffre, J., Piatek, J., &Thill, Y. (2015). Supplier Power: The New Competitive
Differentiator Supply Chain Management Review, 19(2), 53
Hawlena, J. (2012). INFLUENCE OF ALLIANCES, MERGERS AND TAKEOVERS ON
EFFICIENCY OF AIR TRANSPORT.Transport Problems: An International Scientific
Journal, 7(2), 15-26
He, T., & Jackson, P. R (2015). Empirical Study of Trust in Chinese Organizations: Joint
Venture versus State-Owned Enterprise. Journal of Enterprising Culture, 23(2),
139.doi:10.1142/S0218495815500053
Hopson, J. F., & Hopson, P. D. (2014).Making the Right Choice of Business Entity.CPA
Journal, 84(10), 42.
Ibarra, C. A. (2011). Capital Flows and Real Exchange Rate Appreciation in Mexico. World
Development, 39(12), 2080-2090.doi:10.1016/j.worlddev.2011.05.020.
Interfax. (2011, June 8). HisunPharmatoA set upA generics JV with Pfizer. China
Pharmaceuticals & Health Technologies Weekly.P.1
Jin, J. L., Zhou, K. Z., & Wang, Y. (2016).Exploitation and Exploration in International Joint
Ventures Moderating Effects of Partner Control Imbalance and Product
Similarity.Journal of International Marketing, 24(4), 20.doi:10.1509/jim.15.0164
Kumar.V., &Reinartz, W. (2016).Creating Enduring Customer Value. Journal of Marketing,
80(6), 36,doi:10.1509/jm.15.0414
Latif, K. F., &Ullah, M. (2016). An Empirical Investigation into the relationship between
Organizational Culture, Internal Service Quality (ISQ) and Organizational Performance.
Abasyn University Journal of Social Sciences, 9(1), 31-52

Organizational Analysis11
Lee, C., Doong, S., & Chou, P. (2011).Dynamic correlation between stock prices and exchange
rates.Applied Financial Economics, 21 (11), 789. Doi: 10.1080/09603107.2010.537631
Lupsa-Tataru, D. A. (2016).“The organizational culture.A students’ survey.Bulletin of the
Transylvania University of Brasov, Series I: Engineering Sciences, 9(1), 123-128
Madura, J., & Gill, H. 2008. Personal finance. Toronto: Pearson Addison Wesley.
Merger. (2016). Funk &Wagnalls New World Encyclopedia, 1p.1
Mitra, R. (2017). EXCHANGE RATE FLEXIBILITY AND FINANCIAL INTEGRATION:
THE CASE OF FRANCE 1997-2014. Journal of Developing Areas, 51(4), 413-421.
Monopoly. (2016). Funk &Wagnalls New World Encyclopedia, 1p.1
Oxley, J. E., Simpson, R. C., & Silverman, B. S. (2009).Arms Race or Détente? How Interfirm
Alliance Announcements Change the Stock Market Valuation of Rivals. Management
Science, 55(8), 1321
Pfizer to buy Hospira in US$17bn deal, (2015).TCE: The Chemical Engineer, (885), 6
Pilav, A., Jatic, Z. (2017). The impact of organizational culture on patient satisfaction.Journal of
Health Sciences, 7(1), 9-14.doi:10.17532/jhsci.2017.411
Popov, D. (2013). Foreign Investment Multinational Companies and Economic
Development.Proceedings of Novi Sad Faculty Of Law/
ZbornikRadovaPravnogFakuleta, Novi Sad, 47(3), 11-26.doi;10.5937/zrpfns47-4937
Renski, H. (2015). Externalities or Experience?Localization Economies and Start-up Business
Survival.Growth & Change, 46(3), 458-480.doi:10.1111/grow.12099
Schwepker, C.H. (2017). Psychological ethical, leader-member exchange and commitment to
superior customer value: influencing salespeople’s unethical intent and sales
performance. Journal of Personal Selling & Sales Management, 37(1),
72.doi:10.1080/088531334.2016.1272054

Organizational Analysis12
Shu, C., Lu Jin, J., &Zheng Zhou, K. (2017).A Contingent View of Partner Coopetition in
International Joint Ventures. Journal of International Marketing, 25(3), 42
Siddiqui, M. M., Farooq, A. (2017). Consumer Behaviour post Joint Venture Split: An empirical
study on the Indian Automobile Industry. Proceedings of the Multidisciplinary Academic
Conference, 31(40)
Terrero, R. (2017). Stay Unique. Travel Agent, 350(5) 2
Vaidya, S. (2017). IMPACT OF ORGANIZATIONAL CULTURE ON TRUST AND
COMMITMENT IN INTERNATIONAL JOINT VENTURES (IJVS): AN EMPIRICAL
INVESTIGATION. Journal of Competitiveness Studies, 25(2), 100.